7T9A

ApexGT2 in complex with GT2-d42.16 and RM20A3 Fabs

これはPDB形式変換不可エントリーです。

7T9A の概要

• エントリーDOI: 10.2210/pdb7t9a/pdb
• EMDBエントリー: 25754
• 分子名称: HIV Envelope ApexGT2 gp120, alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]alpha-D-mannopyranose-(1-6)-[alpha-D-mannopyranose-(1-3)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, alpha-L-fucopyranose-(1-6)-2-acetamido-2-deoxy-beta-D-glucopyranose, ... (12 entities in total)
• 機能のキーワード: hiv, germline targeting, vaccine, viral protein, viral protein-immune system complex, viral protein/immune system
• 由来する生物種: Human immunodeficiency virus 1; 詳細
• タンパク質・核酸の鎖数: 14
• 化学式量合計: 341446.98

構造登録者

Berndsen, Z.T.,Ward, A.B. (登録日: 2021-12-18, 公開日: 2022-09-28, 最終更新日: 2024-10-30)

• 主引用文献: Melzi, E.,Willis, J.,Ma, K.,Lin, Y.,Kratochvil, S.,Berndsen, Z.T.,Nair, U.,Warner, J.,Steichen, J.,Pecetta, S.,Perez, M.,Kirsch, K.,Ward, A.B.,Schief, W.,Batista, F.D.; Priming HIV Envelope V2 Apex-directed broadly neutralizing antibody responses with protein or mRNA immunogens; Immunity, 2022

実験手法

ELECTRON MICROSCOPY (3.54 Å)